Recruiting
Ovarian cancer: WCS-GY-2208
A Phase 2 study in platinum-resistant disease, evaluating an antibody-drug conjugate as a single agent.
Home/Areas of Study/Gynecologic Cancers
Our commitment to clinical research for gynecologic cancers
Ovarian, endometrial and cervical cancers are often found late and are under-represented in research. Our studies span earlier and later lines of therapy.
3 in 4
ovarian cancers are found only after the disease has spread beyond the ovary
7 studies in this area
Featured trials
A selection of what is open right now. Eligibility is decided by the investigator at a study site, never by this page.
Recruiting
Endometrial cancer: WCS-GY-2231
A randomised Phase 2 study of a combination regimen in advanced or recurrent disease.
Studies open and close continually. We can text you when a new one opens near you.
Get study alertsOur research
What are we studying?
Learn more about our areas of research and see whether one of our clinical trials might be right for you.
Ovarian cancer
- Symptoms are vague and easily attributed to something else, so roughly three quarters of cases are found after the cancer has spread.
- Most people respond to first-line platinum chemotherapy, but the disease commonly returns, and options narrow each time it does.
- Our studies concentrate on platinum-resistant disease, where the need is greatest.
Endometrial and cervical cancer
- Endometrial cancer is the most common gynecologic cancer and its incidence is rising.
- Cervical cancer is largely preventable through vaccination and screening, yet outcomes remain poor where access to both is limited.
- We are studying combination regimens in advanced and recurrent disease.
Want to understand what taking part actually involves before you go further?
Read the guide